Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
90%
OVERLAP
BY WEIGHT
313
# OF OVERLAPPING
HOLDINGS
VHT
420
HOLDINGS
81%
ALSO IN FHLC
FHLC
349
HOLDINGS
97%
ALSO IN VHT
SECTOR DRIFT (VHT minus FHLC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in VHT |
Weight in FHLC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 11.1% | 11.3% | 11.1% |
|
UNITEDHEALTH GROUP INC | 5.0% | 7.3% | 5.0% |
|
ABBVIE INC | 4.8% | 6.1% | 4.8% |
|
JOHNSON & JOHNSON | 4.6% | 6.4% | 4.6% |
|
ABBOTT LABORATORIES | 4.1% | 3.8% | 3.8% |
VHT Overweight Relative to FHLC
|
BOSTON SCIENTIFIC CORP | 0.4% |
|
INTUITIVE SURGICAL INC | 0.4% |
|
ABBOTT LABORATORIES | 0.3% |
|
STRYKER CORP | 0.3% |
|
MCKESSON CORP | 0.3% |
|
CENCORA INC | 0.3% |
|
ALNYLAM PHARMACEUTICALS INC | 0.2% |
|
HCA HOLDINGS INC | 0.2% |
|
CARDINAL HEALTH INC | 0.2% |
|
IDEXX LABORATORIES INC | 0.2% |
VHT Underweight Relative to FHLC
|
UNITEDHEALTH GROUP INC | -2.3% |
|
JOHNSON & JOHNSON | -1.9% |
|
ABBVIE INC | -1.3% |
|
THERMO FISHER SCIENTIFIC INC | -0.5% |
|
BRISTOL-MYERS SQUIBB CO | -0.3% |
|
MERCK & CO. INC. | -0.3% |
|
REGENERON PHARMACEUTICALS | -0.2% |
|
ELI LILLY & CO | -0.2% |
|
BECTON DICKINSON AND CO | -0.2% |
|
INTRA-CELLULAR THERAPIES INC | -0.2% |